Irina Y. Tcherepanova PhD

Dr. Irina Y. Tcherepanova, Ph.D. has served as a chief operating officer since February 2019. Prior to this appointment, Dr. Tcherepanova served as Sr. Director of Research and Development and then Vice President of Translational Medicine at Argos Therapeutics. Dr. Tcherepanova holds multiple patents related to autologous vaccine generation. Dr. Tcherepanova received a Ph.D. in Molecular Pharmacology from the Albert Einstein College of Medicine, going on to complete a post-doctoral fellowship in the Department of Pharmacology and Cancer Biology at the Duke University Medical Center.